New York State Common Retirement Fund Arcus Biosciences, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 13,554 shares of RCUS stock, worth $202,090. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,554
Previous 20,754
34.69%
Holding current value
$202,090
Previous $316,000
34.49%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding RCUS
# of Institutions
200Shares Held
51.5MCall Options Held
236KPut Options Held
141K-
Black Rock Inc. New York, NY9.76MShares$146 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.47MShares$81.5 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.48MShares$51.9 Million0.48% of portfolio
-
State Street Corp Boston, MA3.01MShares$44.9 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.44MShares$36.3 Million0.1% of portfolio
About Arcus Biosciences, Inc.
- Ticker RCUS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 72,160,000
- Market Cap $1.08B
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...